Drug Shortage Report for CLONAZEPAM
Report ID | 13141 |
Drug Identification Number | 02442035 |
Brand name | CLONAZEPAM |
Common or Proper name | CLONAZEPAM |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLONAZEPAM |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AE |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-06-16 |
Actual start date | |
Estimated end date | 2017-06-26 |
Actual end date | 2017-07-23 |
Shortage status | Resolved |
Updated date | 2017-11-06 |
Company comments | Alternate Sivem pack size available (500s) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-16 | English | Compare |
v2 | 2017-06-16 | French | Compare |
v3 | 2017-06-16 | English | Compare |
v4 | 2017-06-16 | French | Compare |
v5 | 2017-06-17 | English | Compare |
v6 | 2017-11-06 | English | Compare |
v7 | 2017-11-06 | French | Compare |
Showing 1 to 7 of 7